Gene: SLC9A2
Official Full Name: solute carrier family 9 member A2provided by HGNC
Gene Summary: This gene encodes a member of the sodium-hydrogen exchanger (NHE) protein family. These proteins are involved in sodium-ion transport by exchanging intracellular hydrogen ions to external sodium ions and help in the regulation of cell pH and volume. The encoded protein is localized to the apical membrane and is involved in apical absorption of sodium. [provided by RefSeq, Jun 2016]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO35380 | SLC9A2 Knockout cell line (HeLa) | Human | SLC9A2 | 1:3~1:6 | Negative | Online Inquiry |
KO35381 | SLC9A2 Knockout cell line (HCT 116) | Human | SLC9A2 | 1:2~1:4 | Negative | Online Inquiry |
KO35382 | SLC9A2 Knockout cell line (A549) | Human | SLC9A2 | 1:3~1:4 | Negative | Online Inquiry |
SLC9A2 Gene Knockout Cell Lines are specifically engineered cellular models that lack expression of the SLC9A2 gene, which encodes the sodium-hydrogen exchanger 2 (NHE2). These cell lines serve as vital tools for elucidating the biological mechanisms and physiological roles of NHE2 in various cellular processes, including ion homeostasis, pH regulation, and cell proliferation. By employing targeted gene editing technologies, such as CRISPR/Cas9, these knockout cell lines facilitate the assessment of the gene's functional consequences on cellular activities and systemic physiology.
The primary function of SLC9A2 is to catalyze the exchange of sodium ions for protons across the plasma membrane, thereby maintaining intracellular pH and supporting nutrient absorption in various tissues, particularly in the gastrointestinal tract and kidney. Understanding the regulatory pathways involving NHE2 is crucial for investigating disease states such as hypertension, metabolic disorders, and cancer. SLC9A2 Gene Knockout Cell Lines provide researchers with a platform for evaluating the effects of pharmacological agents, genetic perturbations, and environmental factors on NHE2 functionality and downstream signaling pathways.
One of the unique selling points of these knockout cell lines is their potential to offer insights into the therapeutic targeting of SLC9A2 in diseases linked to dysregulated ion transport. Unlike traditional models, SLC9A2 knockout lines can yield reproducible and precise data, significantly enhancing the reliability of experimental outcomes. Additionally, these models can be readily utilized in high-throughput screening efforts, thereby accelerating drug discovery processes.
For researchers and clinicians seeking to expand their understanding of ion transport dynamics and its implications in health and disease, SLC9A2 Gene Knockout Cell Lines represent an invaluable resource. They not only advance scientific knowledge but also open pathways for innovative therapeutic approaches. Our company prides itself on providing high-quality, rigorously validated biological products and a commitment to propelling research forward through extensive expertise in genetic engineering and cellular biology.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.